Lantheus Holdings, Inc. LNTH
$105.18
▲ +0.19% 24H
About
Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products to assist clinicians in diagnosing and treating heart disease, cancer, and other conditions worldwide. Its portfolio includes DEFINITY, an injectable ultrasound en…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees808
TickerLNTH
Statistics
Market Cap$6.84B
Revenue (TTM)$1.54B
Net Income$233.6M
Net Margin15.2%
EPS$3.41
P/E24.45
P/S4.31
P/B5.50
EV/EBITDA18.12
ROE23.5%
Dividend Yield—
Price$105.18
Data: Twelve Data · Revenue = mcap / P/S